Division of Hematology and Oncology Archive — Page 10 of 15
-
August 26, 2019
Colorectal cancer researchers receive SPORE funding
Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI). -
August 7, 2019
Colorectal cancer patients warn against dismissing early symptoms
Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms. -
August 1, 2019
Grant bolsters research on myelodysplastic syndromes
Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes. -
July 22, 2019
Encephalitis identified as rare toxicity of immunotherapy treatment
Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies. -
June 18, 2019
Study identifies critical regulator of tumor-specific T cell differentiation
A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work -
June 13, 2019
Eng named to GI cancer leadership position at VICC
Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC). -
April 11, 2019
Study reframes approach to targeted therapy resistance
When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.